Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

Posted by rob on April 22, 2009 under Uncategorized | Comments are off for this article

A population-based cohort was used to determine the incidence and risk factors associated with development of venous thromboembolism (VTE) among Californians diagnosed with acute leukemia between 1993 to 1999. Principal outcomes were deep vein thrombosis in both the lower and upper extremities, pulmonary embolism, and mortality. Among 5394 cases with acute myelogenous leukemia (AML), the 2-year cumulative incidence of VTE was 281 (5.2%). Sixty-four percent of the VTE events occurred within 3 months of AML diagnosis. In AML patients, female sex, older age, number of chronic comorbidities, and presence of a catheter were significant predictors of development of VTE within 1 year. A diagnosis of VTE was not associated with reduced survival in AML patients. Among 2482 cases with acute lymphobl…

4th Circuit Panel Affirms Defense Summary Judgment; Causation Burden Unmet

Posted by rob on under Uncategorized | Comments are off for this article

RICHMOND, Va. – A West Virginia widow seeking to link the death of her husband to occupational exposure to herbicides while employed by a tree service failed to link The Dow Chemical Co. and Dow AgroSciences to the chemicals she alleges caused him to contract chronic myelogenous leukemia, and the trial court grant of summary judgment was not in error, a unanimous Fourth Circuit U.S. Court of Appeals panel said April 8 (Melody White, et al v. The Dow Chemical Co., et al., No. 08-1165, 4th Cir.; 2009 U.S. App. LEXIS 7483; See 4/1/05, Page 16).
Full story on lexis.com (Source: LexisNexis® Mealey’s™ Emerging Toxic Torts Legal News)

Medical Articles 4/22

Posted by rob on under Uncategorized | Be the First to Comment